ClinicalTrials.govpublic full text
A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma
non-small cell lung cancer, adenocarcinoma, recombinant immunotoxin, monoclonal antibody, pseudomonas exotoxin, targeted therapy, lung cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 875974
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.